U.S. Markets closed

Pacira BioSciences, Inc. (PCRX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
61.27+0.20 (+0.33%)
At close: 4:00PM EDT
61.27 -0.00 (-0.00%)
After hours: 04:03PM EDT

Pacira BioSciences, Inc.

5 Sylvan Way
Suite 300
Parsippany, NJ 07054
United States
973 254 3560

IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees624

Key Executives

NameTitlePayExercisedYear Born
Mr. David M. StackChairman & CEO1.59M6.64M1950
Mr. Charles A. Reinhart III, CPA, M.B.A.Chief Financial Officer702.36kN/A1961
Ms. Kristen WilliamsChief Admin. Officer & Sec.788.31k1.72M1974
Mr. Max ReinhardtPres of Rest of World850.16k952.83k1971
Dr. Donald C. Manning M.D., Ph.D.Chief Medical Officer662.59kN/A1959
Ms. Lauren Bullaro RikerPrincipal Accounting Officer & VP of Fin.N/AN/A1979
Mr. Charles LaranjeiraChief Technical OfficerN/AN/A1966
Susan MescoHead of Investor RelationsN/AN/AN/A
Mr. Richard KahrVP of HRN/AN/AN/A
Mr. Robert J. WeilandSr. VP of Alliance ManagementN/AN/A1960
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for health care practitioners and their patients in the United States. The company develops products based on its proprietary DepoFoam product delivery technology that encapsulates drugs without altering their molecular structure. It offers EXPAREL, a bupivacaine liposome injectable suspension, administered at the time of surgery to control pain and reduce or eliminate the use of opioids for acute postsurgical pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature only to targeted nerves. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Parsippany, New Jersey.

Corporate Governance

Pacira BioSciences, Inc.’s ISS Governance QualityScore as of June 1, 2021 is 6. The pillar scores are Audit: 1; Board: 5; Shareholder Rights: 7; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.